<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20090831002391N40</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-10-23</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The effects of training program with virtual reality on women with patellofemoral pain</public_title>
      <acronym></acronym>
      <scientific_title>The effects of training program with virtual reality system on clinical indices and brain mapping of women with patellofemoral pain: A Randomized Clinical Trial study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-03-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>26</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43087</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: All participants are invited to study through advertisements. According to related past studies the sample size estimated 22 subjects (11 subjects per groups) and with considering the 20% attrition with ratio of 1:1 (intervention group:control group) for each of group at least 13 subjects were considered.  Assignment of people to groups will be based on the Block Balanced Randomization (BBR) method. After one month from the end of the study, follow up will be performed in both study groups just on clinical indicators, Randomization description: Assignment of patients in two groups of intervention and control was done by Block Balanced Randomization (BBR) method. The Randomization Sequence is generated with using the free web site at http://www.randomization.com.  Non-transparent and sealed envelopes will be used to conceal the assignment of individuals to groups, Blinding description: The assessor will not be aware of which intervention will be administered to which subject. The data analyzer also does not know the groups (control or intervention).</study_design>
      <phase>2</phase>
      <hc_freetext>Patellofemoral pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group will receive training with XBOX Kinect 360  for 8 weeks in addition to the training provided to the control group. The intervention group will be trained 3 times a week.The games used in this study are from the three packages of Kinect adventures, Kinect Sport and Your Shape Fitness Evolved 2012. The intensity of the games will vary from easy to hard depending on each patient's ability and progress. Each training session lasts about 40 minutes, with each person warm up to 5 minutes before starting the game, and 5 minutes cool down after the game, and practicing XBOX for 30 minutes. All training sessions will be conducted under the supervision of a physiotherapist. Intervention 2: Control group: During the 8 weeks, the control group will continue their daily routine and no intervention will be performed in this group, only training necessary to manage their daily activities (to prevent the development of patellofemoral pain) will be given. educations are provided to people with a prepared text that includes information on how to sit properly, manage of use the stair, proper footwear, no prolonged exposure to a particular situation, use of toilets, etc.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The standard data will be prepared and will be sent to the journal if needed.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Naghmeh Ebrahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Abiverdi street, Chamran blvd</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194733669</zip>
        <telephone>+98 71 3626 1081</telephone>
        <email>n_ebrahimi@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Rojhani Shirazi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Abiverdi 1 street, Chamran blvd</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194733669</zip>
        <telephone>+98 71 3626 1081</telephone>
        <email>rojhaniz@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women between the ages of 18-40 years
Anterior knee pain (in the back or around the patella) for at least 6 months
Pain in the retropatellar area and around the knee in at least 2 of the following activities: prolonged sitting with bent knees, climbing stairs, squatting, running, kneeling, hopping / jumping
Having symptoms in 2 of clinical tests: pain during patellar apprehension test, pain and crepitation during patellar compression test(in fact positive patellofemoral grinding test)
Onset of pain without a history of trauma
Pain in touch of the facet of patella
3 or more pain based on Visual Analogues Scale(VAS) while step up and down from a 25cm step  or on squatting
No pain above 7 on the VAS scale
Lack of visual and neurological problems
Right dominance
Bilateral knee involvement
Kujala questionnaire score less than 83
No use of drugs that affect balance in the past 72 hours</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Knee osteoarthritis
History of knee surgery
History of patellar dislocation
Laxity of ligament
Patellar tendon or cartilage pathology
Referred pain from lumbar spine
Other abnormalities such as leg length discrepancy(more than 2 centimeter)
Physiotherapy or acupuncture in the past three months
History of epilepsy or cardiovascular disease
Pregnancy
Diabetes
Rheumatic diseases
Professional athlete</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M22.40</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chondromalacia patellae, unspecified knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group will receive training with XBOX Kinect 360  for 8 weeks in addition to the training provided to the control group. The intervention group will be trained 3 times a week.The games used in this study are from the three packages of Kinect adventures, Kinect Sport and Your Shape Fitness Evolved 2012. The intensity of the games will vary from easy to hard depending on each patient's ability and progress. Each training session lasts about 40 minutes, with each person warm up to 5 minutes before starting the game, and 5 minutes cool down after the game, and practicing XBOX for 30 minutes. All training sessions will be conducted under the supervision of a physiotherapist.</i_keyword>
      <i_keyword>Control group: During the 8 weeks, the control group will continue their daily routine and no intervention will be performed in this group, only training necessary to manage their daily activities (to prevent the development of patellofemoral pain) will be given. educations are provided to people with a prepared text that includes information on how to sit properly, manage of use the stair, proper footwear, no prolonged exposure to a particular situation, use of toilets, etc.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance. Timepoint: Before intervention and immediately after completion 8 weeks interventionقبل. Method of measurement: Modified Star Excursion Balance Test(SEBT).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life. Timepoint: Before intervention and immediately after completion 8 weeks intervention. Method of measurement: SF-36 (Short Form Health Survey)questionnaire.</sec_outcome>
      <sec_outcome>Function. Timepoint: Before intervention and immediately after completion 8 weeks intervention. Method of measurement: Step down test and Kujala Patellofemoral Scale.</sec_outcome>
      <sec_outcome>Brain mapping. Timepoint: Before intervention and immediately after completion 8 weeks intervention. Method of measurement: Quantitative Electroencephalography(QEEG).</sec_outcome>
      <sec_outcome>Pain. Timepoint: Before intervention and immediately after completion 8 weeks intervention. Method of measurement: Visual Analogue Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-09-18</approval_date>
        <contact_name>Ethics committee of research in Shiraz University of Medical Science</contact_name>
        <contact_address>Central building of Shiraz University of Medical Science, Zand Ave Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
